Assenagon Asset Management S.A. - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 42 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$202,610
-35.5%
158,289
-29.9%
0.00%0.0%
Q1 2023$313,884
+106663.3%
225,8160.0%0.00%0.0%
Q4 2022$294
-99.9%
225,816
-19.3%
0.00%
-50.0%
Q3 2022$414,000
-26.3%
279,981
+1.6%
0.00%0.0%
Q2 2022$562,000275,5520.00%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$5,183,0002.45%
Nan Fung Group Holdings Ltd 1,166,952$3,197,0001.52%
Vivo Capital, LLC 3,871,291$10,607,0000.73%
Samsara BioCapital, LLC 1,049,153$2,875,0000.72%
Novo Holdings A/S 4,503,991$12,341,0000.65%
Sofinnova Investments, Inc. 2,754,437$7,547,0000.57%
Hawkeye Capital Management, LLC 415,039$1,137,0000.45%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,230,250$6,111,0000.19%
Board of Trustees of The Leland Stanford Junior University 719,546$1,972,0000.11%
Echo Street Capital Management LLC 123,804$5,493,0000.04%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders